203 related articles for article (PubMed ID: 26939289)
41. Chemical and structural diversity in cyclooxygenase protein active sites.
Huff RG; Bayram E; Tan H; Knutson ST; Knaggs MH; Richon AB; Santago P; Fetrow JS
Chem Biodivers; 2005 Nov; 2(11):1533-52. PubMed ID: 17191953
[TBL] [Abstract][Full Text] [Related]
42. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
45. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
46. COX-2 Docking Structural Analysis with Phytochemical Extracts of Rosemary: A Possible Cytotoxicity on Head and Neck Squamous Cell Carcinoma Cell Line (HEp-2).
Abd El-Hamid IS; Mouselhy YY; El-Shafei MM; Sayed MM; Mohamed AF; Farag DB
Anticancer Agents Med Chem; 2019; 19(12):1473-1480. PubMed ID: 31244433
[TBL] [Abstract][Full Text] [Related]
47. Toward an optimal docking and free energy calculation scheme in ligand design with application to COX-1 inhibitors.
Shamsudin Y; Gutiérrez-de-Terán H; Boukharta L; Åqvist J
J Chem Inf Model; 2014 May; 54(5):1488-99. PubMed ID: 24786949
[TBL] [Abstract][Full Text] [Related]
48. Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis.
Kakumu A; Ninomiya M; Efdi M; Adfa M; Hayashi M; Tanaka K; Koketsu M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4286-90. PubMed ID: 25074815
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
Dube PN; Bule SS; Mokale SN; Kumbhare MR; Dighe PR; Ushir YV
Chem Biol Drug Des; 2014 Oct; 84(4):409-19. PubMed ID: 24636540
[TBL] [Abstract][Full Text] [Related]
50. Hit identification and biological evaluation of anticancer pyrazolopyrimidines endowed with anti-inflammatory activity.
Alcaro S; Artese A; Botta M; Zizzari AT; Orallo F; Ortuso F; Schenone S; Brullo C; Yáñez M
ChemMedChem; 2010 Aug; 5(8):1242-6. PubMed ID: 20564576
[No Abstract] [Full Text] [Related]
51. Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors.
Radwan AA; elTahir KE
Arch Pharm Res; 2013 May; 36(5):553-63. PubMed ID: 23479193
[TBL] [Abstract][Full Text] [Related]
52. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
53. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.
Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK
Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
[TBL] [Abstract][Full Text] [Related]
56. Nectandra amazonum-derived flavonoids as COX-1 inhibitors: in vitro and docking studies.
Valdés-Barrera ID; Cuca-Suarez LE; Coy-Barrera ED
Nat Prod Commun; 2014 May; 9(5):649-52. PubMed ID: 25026711
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions.
Gundogdu-Hizliates C; Alyuruk H; Gocmenturk M; Ergun Y; Cavas L
Bioorg Chem; 2014 Feb; 52():8-15. PubMed ID: 24270352
[TBL] [Abstract][Full Text] [Related]
59. Proximate Composition Analysis.
Prog Drug Res; 2016; 71():21-31. PubMed ID: 26939262
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors.
Zanatta SD; Manallack DT; Jarrott B; Williams SJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):459-61. PubMed ID: 19056264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
